|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetes Insipidus, Nephrogenic | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Insipidus | |||||
| Diabetes Mellitus | |||||
| 3 | More general conditions related to this trial | ||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Kidney Diseases | |||||
| Metabolic Diseases | |||||
| Pituitary Diseases | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| chlorothiazide | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antihypertensive Agents | |||||
| Cardiovascular Agents | |||||
| Diuretics | |||||
| Membrane Transport Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Natriuretic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sodium Chloride Symporter Inhibitors | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| Northwestern University | |||||